Patents by Inventor Reeder M. Robinson

Reeder M. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER
    Publication number: 20240085427
    Abstract: The present disclosure is directed to antibodies binding to AGR2 and cancer cells that express or overexpress AGR2, and methods for use thereof.
    Type: Application
    Filed: January 4, 2022
    Publication date: March 14, 2024
    Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Nathan G. DOLLOFF, Reeder M. ROBINSON
  • Indene derivatives and uses thereof
    Patent number: 11731952
    Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: August 22, 2023
    Assignees: MUSC Foundation for Research Development, Lukogene Therapeutics Incorporated
    Inventors: Nathan G. Dolloff, Reeder M. Robinson, Allen B. Reitz, Haiyan Bian
  • INDENE DERIVATIVES AND USES THEREOF
    Publication number: 20200165182
    Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
    Type: Application
    Filed: August 29, 2018
    Publication date: May 28, 2020
    Inventors: Nathan G. DOLLOFF, Reeder M. ROBINSON, Allen B. REITZ, Haiyan BIAN
  • Indene derivatives and uses thereof
    Patent number: 10329269
    Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: June 25, 2019
    Assignees: Leukogene Therapeutics Incorporated, MUSC Foundation for Research Development
    Inventors: Nathan G. Dolloff, Reeder M. Robinson, Allen B. Reitz, Haiyan Bian
  • INDENE DERIVATIVES AND USES THEREOF
    Publication number: 20190062298
    Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
    Type: Application
    Filed: August 29, 2018
    Publication date: February 28, 2019
    Inventors: Nathan G. Dolloff, Reeder M. Robinson, Allen B. Reitz, Haiyan Bian